A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin

Pre-clinical studies indicate that cisplatin encapsulated in STEALTH®liposomes (SPI-77) retains anti-tumour activity, but has a much reduced toxicity, compared to native cisplatin. A phase I study was conducted to determine the toxicity and pharmacokinetics of SPI-77 administered to children with ad...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Veal, G J, Griffin, M J, Price, E, Parry, A, Dick, G S, Little, M A, Yule, S M, Morland, B, Estlin, E J, Hale, J P, Pearson, A D J, Welbank, H, Boddy, A V
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2001
Gaiak:
Regular Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363870/
https://ncbi.nlm.nih.gov/pubmed/11308249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.1723
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak